Back to search
FDAFDA · Food and drugs·Recall number D-1168-2018

Azelastine HCl Ophthalmic Solution 0.05%, 6 mL in 10 mL HDPE bottle, 1 bottle per box, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-718-10

Published September 5, 2018 · Recall initiated: August 8, 2018

Summary

FDA records drug Class III recall D-1168-2018, published September 5, 2018 and initiated August 8, 2018. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 8,574 bottles; Lot: Lot# 6K89A, 6K90A, 6K92A, exp 9/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide USA
Lot
Lot# 6K89A, 6K90A, 6K92A, exp 9/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Azelastine HCl Ophthalmic Solution 0.05%, 6 mL in 10 mL HDPE bottle, 1 bottle per box, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-718-10 recalled?

Yes. FDA published recall D-1168-2018 on September 5, 2018. Reported hazard: Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide

What should I do if I have this product?

Voluntary: Firm initiated · Letter